Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.23 new
Vol. 10, Issue 2 (2021)

Community pharmacists’ knowledge about medication use in glucose-6-phosphate-dehydrogenase G6PD deficiency in Khartoum, Sudan: A descriptive study

Author(s):
Ahmad Habeeb Hattab Dala Ali Al-Ani, Sura Habeeb Hattab Habeeb Al-Ani, Rhand T Elkarib and Azza Osman Yousif
Abstract:
Glucose-6-phosphate dehydrogenase G6PD is a cytoplasmic enzymes that are found in all cells of the human body, it plays an essential and vital role in preventing cellular damage from reactive oxygen radicles ROS. Pharmacist can play a major role in providing G6PD deficient patients with the useful information about medications that needs to be avoided in such conditions. Therefore, this study was conducted to assess the pharmacist knowledge about medications use in G6PD deficient patients. Study’s results showed that most of the pharmacists were able to define G6PD deficiency correctly. However, majority were not able to identify risk factors for hemolysis correctly. With regards to the pharmacists’ knowledge about drug usage pattern in G6PD deficient patients, they showed an overall good knowledge as they were able to correctly identify the contraindicated and used with caution medications. Pharmacists should use continuous pharmaceutical education to keep up with updated evidence based information regarding medication use in specific population such as G6PD deficient individuals especially in G6PD prevalent regions.
Pages: 18-21  |  48 Views  9 Downloads
How to cite this article:
Ahmad Habeeb Hattab Dala Ali Al-Ani, Sura Habeeb Hattab Habeeb Al-Ani, Rhand T Elkarib, Azza Osman Yousif. Community pharmacists’ knowledge about medication use in glucose-6-phosphate-dehydrogenase G6PD deficiency in Khartoum, Sudan: A descriptive study. Pharma Innovation 2021;10(2):18-21. DOI: 10.22271/tpi.2021.v10.i2a.5675
The Pharma Innovation Journal